- Full portfolio of Kuida products will be exhibited at the
event's Discover Beauty Pavilion to over 40,000 retail buyers,
distributors, and beauty industry professionals
- Kuida is the first Colombian mass-market CBD cosmeceutical
brand to showcase at Cosmoprof
- Participation in Cosmoprof North America marks crucial step
towards expansion of Kuida into the
United States, subject to TSX approval, targeting
$20 billion dollar U.S. cosmetic
market (Euromonitor)
- Further solidifies strong relationship between Kuida and a
growing network of retailers, distributors and buyers, as the brand
continues to experience strong demand
- Kuida the only CBD skin care product line available at retail
in Colombia
TORONTO, July 16, 2019 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN),
(OTCQB: KHRNF), (Frankfurt:
A2JMZC), a vertically integrated cannabis leader with core
operations in Latin America, announced today that the Company
will participate in Cosmoprof North America, taking place July
28 – July 30 at the Mandalay Bay
Convention Center in Las Vegas,
Nevada. Recognized as the leading B2B beauty event in
North America, this event will
present the Company's Kuida cosmeceutical portfolio to a vast
network of U.S. retailers, distributors and buyers, as the Company
targets U.S. consumers through its previously announced Joint
Venture with Dixie Brands.
With over 40,000 expected attendees, Cosmoprof North America is
known by the beauty industry as a hub to discover best-in-class
brand launches and product innovations, new channels for
distribution, packaging, and manufacturing, and to form key
relationships with top industry professionals and retailers. The
Company was previously invited to present at Cosmoprof Worldwide
Bologna earlier this year, where it became the first Colombian
mass-market CBD cosmeceutical brand to showcase at Cosmoprof in
March 2019.
Elsa Navarro, Skin Unit Director,
Khiron Life Sciences, states: "After an overwhelmingly positive
response at Cosmoprof Worldwide Bologna, we are thrilled to exhibit
at Cosmoprof North America 2019. As we continue to experience
strong demand for the Kuida brand, our participation at this
widely-respected industry event underscores our proven product
development expertise and further solidifies our relationship with
a growing network of retailers, distributors and buyers."
Launched in October 2018, Kuida is
the first brand in Colombia that brings the benefits of
Cannabidiol (CBD) to a comprehensive portfolio of skin and body
care products for women, and as such Kuida remains the only
CBD skin care product line available at retail in the
country. Since the initial exclusive launch of the product
with Colombian retailer Farmatodo, Khiron has secured distribution
arrangements with many of the largest retailers in the Colombian
market, including Fedco, Linio, Droguerias Cafam, Habib, Galenos,
and Salud Market. Collectively,
these companies represent over 176 retail points of sales as well
as significant online distribution platforms.
Through a 50/50 joint venture with Dixie
Brands, one of the cannabis industry's leading consumer
packaged goods companies, Khiron now intends to introduce
Kuida to the US market, subject to TSX approval, combining its
portfolio of proven product formulations with Dixie's established
marketing and distribution expertise to accelerate market access
and entry across the United
States. Building upon its participation at Foundermade East,
an influential beauty and wellness summit which took place in
June 2019 in New York City, Kuida's presence at Cosmoprof
North America will further lay the foundation for the brand's entry
in the United States, representing
the next milestone in Kuida's expansion to the $20 billion U.S. cosmetic market.
Visit Khiron at Booth 42018 at the Discover Beauty Pavilion at
Cosmoprof North America.
About Cosmoprof North America
Cosmoprof North
America (CPNA) is the award winning premier international B2B
beauty trade show covering all facets of the industry under one
roof and the largest event of its kind in the Americas. For more
information, please visit www.cosmoprofnorthamerica.com. Event
information and exhibitor updates are also posted on Facebook,
Twitter (@cosmoproflv) and Instagram (@cosmoprofna).
About Khiron Life Sciences Corp.
Khiron Life Sciences
Corp. is positioned to be the dominant integrated cannabis company
in Latin America. Khiron has core
operations in Colombia and is
fully licensed in the country for the cultivation, production,
domestic distribution, and international export of both THC
(tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. The
company delivers best in class regulatory compliance, has the first
approved CBD cosmetic products on shelf, while it facilitates
testing to meet and surpass all license requirements for commercial
cannabis derived products.
With a focused regional strategy and patient oriented approach,
the Company combines global scientific expertise, agricultural
advantages, branded product market entrance experience and
education to drive prescription and brand loyalty to address
priority medical conditions such as chronic pain, epilepsy,
depression and anxiety in the Latin American market of over 620
million people. Khiron is led by Co-founder and Chief Executive
Officer, Alvaro Torres, together
with an experienced executive team, and a knowledgeable Board of
Directors that includes former President of Mexico, Vicente
Fox.
Further information on Khiron Life Sciences can be found
at www.khiron.ca.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Forward-looking statements herein include, but are not
limited to, statements regarding the final approval of the TSXV and
the introduction of Kuida to the United
States market. Khiron undertakes no obligation to
comment analyses, expectations or statements made by third-parties
in respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and are made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
United States Disclaimer
This news release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities
in the United States. The securities have not been and
will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") or any state
securities laws and may not be offered or sold
within the United States or to U.S. Persons (as such term
is defined in Regulation S under the U.S. Securities Act) unless
registered under the U.S. Securities Act and applicable state
securities laws or an exemption from such registration is
available
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-targets-over-40-000-beauty-industry-leaders-with-kuida-skin-care-brand-at-cosmoprof-north-america-300885314.html
SOURCE Khiron Life Sciences Corp.